M-Biotech Inc.
This article was originally published in Start Up
Executive Summary
M-Biotech's novel approach to continuous glucose monitoring employs a proprietary hydrogel-based sensor implanted in subcutaneous tissue. Unlike those of its competitors, this sensor registers changes in pressure, minimizing the impact of background noise created by other biomolecules.